Essais liés10clinical trials
VilleCalgarylocalisation
PaysCanadalocalisation
SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT05691478

Ouvrir le site du centre

Essais cliniques associés

10
MoléculeIndication / populationPhaseNCTTitreStatut
Biopsy Procedure Cancer Phase 2 NCT06064097 A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC) RECRUITING
Emapalumab Lupus Phase 3 NCT05001737 EMERALD — Evaluate Efficacy, Safety and Tolerability, PK and PD of Emapalumab in Children and Adults With MAS in Still's or SLE COMPLETED
Active Remote Electrical Neuromodulation Migraine Non applicable NCT07772427 Neuromodulation During the Prodrome to Prevent Disabling Migraine Attacks in Youth NOT_YET_RECRUITING
NS-050/NCNP-03 Myopathies Phase 1/2 NCT06053814 NS-050/NCNP-03 in Boys With DMD (Meteor50) ACTIVE_NOT_RECRUITING
Biospecimen Collection Cancer Phase 3 NCT05675410 A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab RECRUITING
Bone Scan Cancer Phase 2/3 NCT05691478 A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma SUSPENDED
PF-06939926 Myopathies Phase 3 NCT04281485 Study to Evaluate the Safety and Efficacy of PF-06939926 for the Treatment of Duchenne Muscular Dystrophy ACTIVE_NOT_RECRUITING
SGT-003 Myopathies Phase 3 NCT07160634 A Study of SGT-003 Gene Therapy in Ambulant Males With Duchenne Muscular Dystrophy (IMPACT DUCHENNE) RECRUITING
Lung Volume Recruitment (LVR) Myopathies Phase 4 NCT01999075 STEADFAST — Stacking Exercises Aid the Decline in FVC and Sick Time COMPLETED
Casimersen Myopathies Phase 3 NCT03532542 An Extension Study to Evaluate Casimersen or Golodirsen in Patients With Duchenne Muscular Dystrophy TERMINATED